NEW YORK ( TheStreet) -- CHANGE IN RATINGS:
Arthur J. Gallagher
upgraded at KBW to Outperform, Keefe, Bruyette & Woods said. $45 price target. Company is seeing strong organic growth and expanding margins.
Arthur J. Gallagher upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. Company is carrying a lot of momentum into 2013. $41 price target.
(CIT - Get Report)
downgraded at Morgan Stanley from Overweight to Equal-weight, Morgan Stanley said. $46 price target. Management is turning the business around, but the company lacks near-term catalysts.
downgraded at Bernstein from Market Perform to Underperform, Bernstein Research said. Valuation call, based on a $27 price target.
upgraded at BofA/Merrill to Buy, Bank of America/Merrill Lynch said. $84 price target. Cloud and mobility can continue to drive growth.
Endo Health Solutions
downgraded at Oppenheimer to Perform from Outperform, Oppenheimer said. Valuation call.
(FB - Get Report)
downgraded at Citigroup to Neutral from Buy, Citigroup said. $30 price target. Heavy investment mode.
Facebook downgraded at BMO to Market Perform, BMO Capital said. Valuation call, based on a $32 price target.
Facebook upgraded at Pivotal from Hold to Buy, Pivotal Research said. $36 price target. Visibility is improving for 2013.
downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. $17 price target. Company lacks near-term visibility.
Fusion-io downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $21 price target. Consensus revenue estimates need to move materially lower.
Fusion-io upgraded at Lazard from Neutral to Buy, Lazard Capital Markets said. $23 price target. Business is lumpy, but the stock is attractively valued at current levels.
(HES - Get Report)
downgraded at UBS to Neutral from Buy, UBS said. $70 price target. Downgraded after recent rally.
upgraded at JP Morgan to Neutral, JP Morgan said. Sector is improving and the company is paying down debt.
upgraded at Needham to Buy from Hold, Needham said. $18 price target. Company is realizing higher margins and demand in Europe appears to have bottomed.